To understand the drivers of antibiotic resistance emergence and spread, particularly in carbapenem-resistant Klebsiella pneumoniae.
Key Findings:
Phylogenetic analysis revealed differences in the contribution of de novo evolution and cross-transmission to resistance against five antibiotics, highlighting the need for targeted interventions.
Exposure to specific antibiotics was identified as an independent risk factor for both resistance emergence and spread.
Unique clinical risk factors, including comorbidities and medical devices, were associated with resistance spread.
Interpretation:
The study highlights the importance of distinguishing between different pathways of resistance acquisition to inform targeted intervention strategies.
Limitations:
The study was limited to a specific geographic area and patient population, which may affect the generalizability of the findings to other regions.
Data on antibiotic exposure was limited to the duration of hospital stay, potentially missing prior exposures.
Conclusion:
A phylogenetic framework can enhance understanding of antibiotic resistance dynamics, guiding tailored prevention strategies in clinical settings and informing future research.
